Melanoma/Skin Cancer

Top Story

Dermatologist: Many Hispanics don't believe they're at risk for skin cancer

Dermatologist: Many Hispanics don't believe they're at risk for skin cancer
March 22, 2017

Although many Hispanic people believe they are not at risk for skin cancer, the population is more likely to be diagnosed with the disease in more advanced stages, according to a presenter at the American Academy of Dermatology Annual Meeting in Orlando, Florida.

“The belief that Hispanic people don’t have to worry about skin cancer has existed among Latinos for generations,” Maritza I. Perez, MD, FAAD, clinical professor of dermatology at the Icahn School of Medicine at Mount Sinai, New York, who presented “Skin Cancer in Latinos 2017 what’s new” at a scientific session, stated in a press release from AAD. “They hear it from their parents and then they pass this belief on to their children.”

‘We can do better’: ASCO report outlines persistent health care disparities, need for funding

March 22, 2017
Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to ASCO’s State of
Meeting NewsVideo

VIDEO: Sancy Leachman, MD, PhD, FAAD, discusses 'War on Melanoma' registry

March 22, 2017
ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Sancy Leachman, MD, PhD, FAAD, discusses Oregon Health and…
Meeting NewsVideo

VIDEO: Resurgence of cutaneous radiation therapy for skin cancer

March 21, 2017
ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Clay J. Cockerell, MD, discusses the resurgence of cutaneous…
CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Video
Meeting News

VIDEO: Resurgence of cutaneous radiation therapy for skin cancer

March 21, 2017
More »
Featured
HEMONC TODAY Melanoma and Cutaneous Malignancies

HEMONC TODAY Melanoma and Cutaneous Malignancies

CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately…
More »
Meeting News Coverage

Dermatologist: Many Hispanics don't believe they're at risk for skin cancer

March 22, 2017
Although many Hispanic people believe they are not at risk for skin cancer, the population is more likely to be diagnosed with the disease in more…

‘We can do better’: ASCO report outlines persistent health care disparities, need for funding

March 22, 2017
Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to…

Meeting NewsVideo

VIDEO: Sancy Leachman, MD, PhD, FAAD, discusses 'War on Melanoma' registry

March 22, 2017
ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Sancy Leachman, MD, PhD, FAAD,

Meeting NewsVideo

VIDEO: Resurgence of cutaneous radiation therapy for skin cancer

March 21, 2017
ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Clay J. Cockerell, MD, discusses the…

In the Journals

Cancer surveillance guidelines lack specificity, consistency

March 20, 2017
Recommendations for surveillance after cancer treatment in survivors across guidelines are often nonspecific and inconsistent; therefore…

Beth Israel Deaconess Medical Center appoints dermatology chief

March 19, 2017
Suzanne Olbricht , MD, has been appointed chief of dermatology at Beth Israel Deaconess Medical Center. Olbricht will succeed…

Leading cancer organizations: Trump’s proposed NIH budget cuts will threaten research, patient care

March 17, 2017
Many of the nation’s leading research organizations and cancer centers have voiced their opposition to President Donald J. Trump’s…

In the Journals

Study: Dermascope use in primary care is low, but the device is beneficial

March 16, 2017
Dermoscopy could assist osteopathic primary care physicians improve their diagnostic accuracy for skin cancer, thus preventing unwarranted referrals…

Open-access ‘knowledgebase’ focuses on clinical relevance of cancer gene mutations

March 16, 2017
Cancer researchers at Washington University School of Medicine in St. Louis have developed an online cancer database designed to streamline the…

Perspective

White paper outlines progress, challenges of immunotherapy in community setting

March 15, 2017
The Association of Community Cancer Centers’ Institute for Clinical Immuno-Oncology issued a white paper titled “Immuno-Oncology…

More Headlines »
Advertisement
Advertisement